Search hospitals > Michigan > Kalamazoo

Ascension Borgess Cancer Center

Claim this profile
Kalamazoo, Michigan 49009
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
81 reported clinical trials
1 medical researcher
Photo of Ascension Borgess Cancer Center in KalamazooPhoto of Ascension Borgess Cancer Center in KalamazooPhoto of Ascension Borgess Cancer Center in Kalamazoo

Summary

Ascension Borgess Cancer Center is a medical facility located in Kalamazoo, Michigan. This center is recognized for care of Cancer, Lung Cancer, Adenocarcinoma, Breast Cancer, Non-Small Cell Lung Cancer and other specialties. Ascension Borgess Cancer Center is involved with conducting 81 clinical trials across 249 conditions. There are 1 research doctors associated with this hospital, such as Kathleen J. Yost.

Area of expertise

1Cancer
Global Leader
Ascension Borgess Cancer Center has run 28 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Lung Cancer
Global Leader
Ascension Borgess Cancer Center has run 12 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II

Top PIs

Clinical Trials running at Ascension Borgess Cancer Center

Breast Cancer
Melanoma
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Bladder Cancer
Cutaneous Melanoma
Pancreatic Cancer
Gastric Cancer
Multiple Myeloma
Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Support Program

for Breast Cancer

This study is evaluating whether a support program may help breast cancer patients take their medication correctly.
Recruiting2 awards Phase 34 criteria
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Ascension Borgess Cancer Center?
Ascension Borgess Cancer Center is a medical facility located in Kalamazoo, Michigan. This center is recognized for care of Cancer, Lung Cancer, Adenocarcinoma, Breast Cancer, Non-Small Cell Lung Cancer and other specialties. Ascension Borgess Cancer Center is involved with conducting 81 clinical trials across 249 conditions. There are 1 research doctors associated with this hospital, such as Kathleen J. Yost.